Spectral AI Inc (NASDAQ:MDAI) announced that it has received a $1 million investment from an affiliate of its largest shareholder into its newly created subsidiary Spectral IP.
Spectral IP will be focused on developing intellectual property for the broader AI ecosystem through acquisitions, strategic partnerships, and collaborations with AI technology providers, healthcare institutions, and research organizations.
"Following our recent announcement that we had identified additional opportunities for Spectral AI to enhance its position and add value for its shareholders by developing or acquiring IP applicable to the broader AI ecosystem, we received a very attractive proposal to provide financing to Spectral IP from our largest outside shareholder, who also happens to be a recognized IP industry-leader,” Spectral AI CEO Peter Carlson said in a statement.
"While we recognize the opportunities created by Spectral IP, management is of the view that any capital required for this initiative should be funded separately so that the company can deploy its capital to pursue our core operations."
Spectral AI chief innovation strategist Wensheng Fan added: “We see tremendous benefits to developing and acquiring IP outside our core product offering that will protect the developing AI healthcare ecosystem.”
The company said it remains dedicated to progressing AI-driven solutions in healthcare, including through opportunities and strategic developments fostered by its new subsidiary.
Dallas, Texas-based Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers.